| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Chandra, C. S. Julie
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (1/1 displayed)
Places of action
| Organizations | Location | People |
|---|
article
Green Synthesis of CuO/ZnO Nanocomposites using Ficus Drupacea: In‐Vitro Antibacterial and Cytotoxicity Analysis
Abstract
<jats:title>Abstract</jats:title><jats:p>With the increasing demand for environmentally friendly and effective biomedical solutions, the synthesis of nanoparticles with enhanced properties has become imperative. This study addresses this demand by employing a green method that utilizes <jats:italic>Ficus Drupacea</jats:italic> fruit extract to produce ZnO/CuO nanostructures, offering versatile biomedical applications. While several reports exist on the synthesis of nanostructures using plant extracts, this is the primary report on the utilization of <jats:italic>Ficus Drupacea</jats:italic> fruit extract for creating ZnO/CuO nanostructures. A series of five ZnO/CuO nanostructures (<jats:bold>ZC0</jats:bold>, <jats:bold>ZC25</jats:bold>, <jats:bold>ZC50</jats:bold>, <jats:bold>ZC75</jats:bold>, and <jats:bold>ZC100</jats:bold>) were synthesized by varying the proportion of CuO and ZnO. Through comprehensive characterization techniques including XRD (X‐Ray Diffraction), HR‐TEM (High‐Resolution Transmission Electron Microscopy), and UV‐Vis spectroscopy, the successful synthesis and tunable properties of the nanostructures were confirmed, with average crystal sizes ranging from 14.32 nm to 38.61 nm. The study unveils the significant cytotoxicity of the synthesized nanostructures against MCF‐7 breast cancer cells, with <jats:bold>ZC25</jats:bold> demonstrating the highest activity and an LC50 (Lethal Concentration 50) value below 50 μg/mL. Antimicrobial assays underscore the potent activity of <jats:bold>ZC100</jats:bold> against <jats:italic>Streptococcus mutans</jats:italic> and <jats:italic>Acinetobacter baumannii</jats:italic>, with MIC (Minimum Inhibitory Concentration) values below 1.5 mg/mL. These findings emphasize the potential of these nanostructures for advanced biomedical applications.</jats:p>